North America Pacemakers Market Outlook and Strategic Insights by 2027

The North America pacemakers market is expected to reach US$ 5,144.2 Mn in 2027 from US$ 2,607.1 Mn in 2018. The market is estimated to grow with a CAGR of 8.0% from 2019-2027.

Key factors that are driving the growth of the market are rising incidence of cardiovascular diseases, significant geriatric population present in the region that is susceptible to the risk of chronic heart diseases and presence of key players in the market and major technological advancements made by the North American players in the market.

Cardiovascular diseases represent a class of multiple diseases related to blood vessels and heart. According to the World Health Organization 2017, approximately 90% of cardiovascular diseases are preventable. The WHO also states that CVD is the leading cause of death in US and worldwide. In 2017, according to the World health organization, the increasing prevalence of cardiovascular diseases is the major cause of death all over the world. Cardiovascular disease is one of the leading causes of morbidity and mortality and is responsible for 30% of worldwide mortality, according to the World Health Organization. Moreover, according to the Centers of Disease Control and Prevention, Coronary heart disease (CHD) is the most common type of heart disease, killing over 370,000 people annually. Furthermore, according to the American Heart Association, in 2016, Coronary Heart Disease was the leading cause (43.2%) of deaths attributable to cardiovascular disease in the US, followed by stroke (16.9%), High Blood Pressure (9.8%), Heart Failure (9.3%), diseases of the arteries (3.0%), and other cardiovascular diseases (17.7%). Thus, such a high prevalence of cardiovascular diseases globally is anticipated to lead the market growth in the coming years.

The pacemakers market, based on product type, is segmented into implantable pacemakers and external pacemakers. In 2018, the implantable pacemakers segment held the largest share of the market, by product type. Moreover, the same segment of pacemakers market is also expected to witness growth in its demand at the fastest CAGR of 8.3% from 2019 to 2027. The spurring adoption of these devices relies majorly on the availability of reimbursement that results in reducing the economic burden on the patients in the developed economies that have a high prevalence of cardiovascular diseases. Moreover, the implantable pacemakers are highly penetrated in the market and thus are adopted as a first preference due to low risk, and other advantages offered by these devices.

NORTH AMERICA PACEMAKERS– MARKET SEGMENTATION

By Product Type

• Implantable Pacemakers
• External Pacemakers

By Technology

• Single Chambered
• Dual Chambered
• Bi-Ventricular

By End User

• Hospitals
• Ambulatory Surgical Centres
• Others

By Country

• U.S
• Canada
• Mexico

Companies Mentioned

• Medico S.p.A.
• Vitatron
• Abbott
• Medtronic
• OSCOR
• LivaNova Plc
• Abiomed
• Boston Scientific Corporation
• Biotronik
• Lepu Medical

North America Pacemakers Report Scope